BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9121219)

  • 1. [Pulmonary hemorrhage and acute respiratory failure secondary to thrombolytic treatment with tissue plasminogen activator (rt-PA) in patients with acute myocardial infarction].
    Sandar Núñez D; Ruiz Santana S; García Jiménez A; Castro Mao M
    Med Clin (Barc); 1997 Mar; 108(8):318. PubMed ID: 9121219
    [No Abstract]   [Full Text] [Related]  

  • 2. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebral hemorrhage after thrombolytic therapy managed with ventricular drainage.
    Al-Khawaja D; Eslick GD; Fuller SJ; Seex K
    J Clin Neurosci; 2007 Sep; 14(9):898-900. PubMed ID: 17660059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombolytic therapy in acute myocardial infarct and pulmonary artery thromboembolism].
    Iakovlev VB; Gospodarenko AL; Makarenko AS
    Voen Med Zh; 1993 Jun; (6):45-7. PubMed ID: 8367952
    [No Abstract]   [Full Text] [Related]  

  • 5. Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction.
    Massel D; Gill JB; Cairns JA
    Can J Cardiol; 1991 Sep; 7(7):298-302. PubMed ID: 1933636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ischemic ictus during thrombolytic treatment in acute myocardial infarct].
    Seijo-Martínez M; Pais A; Castro del Río M; Silva-Martínez M
    Rev Neurol; 2000 Oct 16-31; 31(8):798-9. PubMed ID: 11082894
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intracranial hemorrhage following second thrombolytic treatment of myocardial reinfarction].
    Valentín Segura V; Valls Grima F; Broch Porcar MJ; Miralles Serrano L; Olivares Toledo D; Alvarez Cebrián F
    Rev Esp Cardiol; 1994 Dec; 47(12):836-8. PubMed ID: 7855379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke associated with thrombolytic therapy for acute myocardial infarction.
    Sloan MA
    Heart Dis Stroke; 1992; 1(5):287-94. PubMed ID: 1344119
    [No Abstract]   [Full Text] [Related]  

  • 9. Diffuse pulmonary hemorrhage complicating thrombolytic therapy for acute myocardial infarction.
    Gopalakrishnan D; Tioran T; Emanuel C; Clark VL
    Clin Cardiol; 1997 Mar; 20(3):298-300. PubMed ID: 9068920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator.
    Ben-Chitrit S; Korzets Z; Hershkovitz R; Bernheim J; Schneider M; Bernheim J
    Nephrol Dial Transplant; 1994; 9(4):428-30. PubMed ID: 8084460
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
    van Griensven JM; Koster RW; Burggraaf J; Huisman LG; Kluft C; Kroon R; Schoemaker RC; Cohen AF
    Clin Pharmacol Ther; 1998 Jan; 63(1):39-47. PubMed ID: 9465840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
    García-Jiménez A; Iriarte Sotés P; Fernández González CJ; Garrote Freire A; González Tutor J
    An Med Interna; 2003 Mar; 20(3):163-4. PubMed ID: 12756909
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.
    Chorich LJ; Derick RJ; Chambers RB; Cahill KV; Quartetti EJ; Fry JA; Bush CA
    Ophthalmology; 1998 Mar; 105(3):428-31. PubMed ID: 9499772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoptysis and unilateral intra-alveolar hemorrhage complicating intravenous thrombolysis for myocardial infarction.
    Hammoudeh AJ; Haft JI; Eichman GT
    Clin Cardiol; 1996 Jul; 19(7):595-6. PubMed ID: 8818443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombolytic therapy for myocardial infarction in oral anticoagulation].
    Pizzulli L; Lüderitz B
    Dtsch Med Wochenschr; 1996 Mar; 121(13):424. PubMed ID: 8681737
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lingual haematoma after thrombolysis for acute myocardial infarction].
    Jaffrelot M; Bourrigan P; Cracan A; Dewilde J; Mehu G
    Ann Fr Anesth Reanim; 2005 Mar; 24(3):306-7. PubMed ID: 15792570
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anaphylactoid reaction during administration of tissue plasminogen activator (t-PA)].
    Cannas S; De Leo A; Marzari A
    G Ital Cardiol; 1997 Mar; 27(3):278-80. PubMed ID: 9244730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does 'front-loading' with rt-PA improve treatment of acute myocardial infarction?
    Vine DL
    Kans Med; 1993 Apr; 94(4):116, 115. PubMed ID: 8487458
    [No Abstract]   [Full Text] [Related]  

  • 19. Parapharyngeal hemorrhage secondary to thrombolytic therapy for acute myocardial infarction.
    Scuba JR; Parrado C
    J Oral Maxillofac Surg; 1992 Apr; 50(4):413-5. PubMed ID: 1545300
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.